Methylenetetrahydrofolate reductase gene C677T polymorphism, homocysteine, vitamin B12, and DNA damage in coronary artery disease

Human Genetics

Volumn 112, Issue 2, 2003, Pages 171-177

  Andreassi, Maria Grazia ^a   Botto, Nicoletta ^a   Cocci, Franca ^b   Battaglia, Debora ^b   Antonioli, Elisabetta ^a   Masetti, Serena ^a   Manfredi, Samantha ^a   Colombo, Maria Giovanna ^a   Biagini, Andrea ^a   Clerico, Aldo ^a  

^a G PASQUINUCCI HOSPITAL   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ACETYLSALICYLIC ACID; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BIOLOGICAL MARKER; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; CHOLINESTERASE INHIBITOR; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; NITRATE; TRIACYLGLYCEROL; CYTOSINE; DNA; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); OXIDOREDUCTASE; PRIMER DNA; THYMIDINE;

ADULT; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ANGIOGRAPHY; ARTICLE; ASSAY; ATHEROSCLEROSIS; C677T GENE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE SEVERITY; DNA DAMAGE; DYSLIPIDEMIA; ENZYME POLYMORPHISM; FEMALE; GENE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; HYPERTENSION; LYMPHOCYTE; MALE; MICRONUCLEUS; NUTRITIONAL DEFICIENCY; PRIORITY JOURNAL; RISK FACTOR; VASCULAR DISEASE; VITAMIN BLOOD LEVEL; AGED; ALLELE; ANGIOCARDIOGRAPHY; BLOOD; CAROTID ARTERY DISEASE; CHEMISTRY; GENETICS; METABOLISM; MICRONUCLEUS TEST; MIDDLE AGED; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLYMERASE CHAIN REACTION;

AGED; ALLELES; CAROTID ARTERY DISEASES; CORONARY ANGIOGRAPHY; CYTOSINE; DNA; DNA DAMAGE; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; FEMALE; FOLIC ACID; GENOTYPE; HOMOCYSTEINE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MICRONUCLEUS TESTS; MIDDLE AGED; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK FACTORS; THYMIDINE; VITAMIN B 12;

EID: 0037316039     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00439-002-0859-3     Document Type: Article

References (48)

1. Andreassi MG, Botto N, Colombo MG, Biagini A, Clerico A (2000) Genetic instability and atherosclerosis: Can somatic mutations account for the development of cardiovascular disease? Environ Mol Mutagen 35:265-269
2. Andreassi MG, Botto N, Rizza A, Colombo MG, Palmieri C, Berti S, Manfredi S, Masetti S, Clerico A, Biagini A (2002) Deoxyribonucleic acid damage in human lymphocytes after percutaneous transluminal coronary angioplasty J Am Coll Cardiol 40:862-868
3. Benditt EP, Benditt JM (1973) Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci USA 70:1753-1756
4. Bennett T, Bennet MR (2001) Reactive oxygen species: Oxidative DNA damage in atherosclerosis. Cir Res 88:648-650
5. Blount BC, Mack MM, Wehr CM, MacGregory JT, Hiatt RA, Wang G, Wickramasinghe SN, Everson RB, Ames BN (1997) Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: Implication for cancer and neuronal damage. Proc Natl Acad Sci USA 94:3290-3295
6. Botto N, Rizza A, Colombo MG, Mazzone AM, Manfredi S, Masetti S, Clerico A, Biagini A, Andreassi MG (2001) Evidence for DNA damage in patients with coronary artery disease. Mutat Res 493:23-30
7. Breteler MM (2000) Vascular involvement in cognitive decline and dementia. Epidemiologic evidence from the Rotterdam Study and the Rotterdam Scan Study. Ann N Y Acad Sci 903: 457-465
8. Chen Z, Karaplis AC, Ackerman SL, Pogribny IP, Melnyk S, Lussier-Cacan S, Chen MF, Pai A, John SW, Smith RS, Bottiglieri T, Bagley P, Selhub J, Rudnicki MA, James SJ, Rozen R (2001) Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum Mol Genet 10:433-443
9. Crott JW, Fenech M (1999) Effect of vitamin C supplementation on chromosome damage, apoptosis and necrosis ex vivo. Carcinogenesis 20:1035-1041
10. Crott, J. Fenech M (2001) Preliminary study of the genotoxic potential of homocysteine in human lymphocytes in vitro. Mutagenesis 16:213-217
11. Crott JW, Mashiyama ST, Ames BN, Fenech MF (2001a) Methylenetetrahydrofolate reductase C677T polymorphism does not alter folic acid deficiency-induced uracil incorporation into primary human lymphocyte DNA in vitro. Carcinogenesis 22:1019-1025
12. Crott JW, Mashiyama ST, Ames BN, Fenech M (2001b) The effect of folic acid deficiency and MTHFR C677T polymorphism on chromosome damage in human lymphocytes in vitro. Cancer Epidemiol Biomarkers Prev 10:1089-1096
13. De Flora S, Izzotti A, Walsh D, Degan, P, Petrilli GL, Lewtas J (1997) Molecular epidemiology of atherosclerosis. FASEB J 11:1021-1031
14. Esteller M, Garcia A, Martinez-Palones JM, Xercavins J, Reventos J (1997) Germ line polymorphisms in cytocrome-P450 1A1 (C4887 CYP1A1) and methylenetetrahydrofolate reductase (MTHFR) genes and endometrial cancer susceptibility. Carcinogenesis 18:2307-2311
15. Fenech M (1993) The cytokinesis-block micronucleus technique and its application to genotoxicity studies in human population. Environ Health Perspect 101:101-107
16. Fenech M (2001) The role of folic acid and vitamin B12 in genomic stability of human cells. Mutat Res 475:57-67
17. Fenech M, Dreosti IE, Rinaldi JR (1997) Folate, vitamin B12, homocysteine status and chromosome damage rate in lymphocytes of older men. Carcinogenesis 18:1329-1336
18. Fenech M, Aitken C, Rinaldi JR (1998) Folate, vitamin B12, homocysteine status and chromosome damage in young Australian adults. Carcinogenesis 19:1163-1171
19. Fletcher O, Kessling AM (1998) MTHFR association with atherosclerotic vascular disease? Hum Genet 103:11-21
20. Frisco S, Choi SW, Girelli D, Mason JB, Dolnikowski GG, Bagley PJ, Olivieri O, Jacques PF, Rosenberg IH, Corrocher R, Selhub J (2002) A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci USA 99:5606-5611
21. Frosst P, Blom HJ, Milos R, Gryette P, Sheppard CA, Matthews RG, Boers GJH, Den Heijer M, Kluijtmans LAJ, Van Den Heuvelo LP, Rozen R (1995) A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113
22. Gershoni-Baruch R, Dagan E, Israeli D, Kasinetz L, Kadouri E, Friedman E (2000) Association of the C677T polymorphism in the MTHFR gene with breast and/or ovarian cancer risk in Jewish women. Eur J Cancer 36:2313-2316
23. Huang RF, Huang SM, Lin BS, Wei JS, Liu TZ (2001) Homocysteine thiolactone induces apoptotic DNA damage mediated by increased intracellular hydrogen peroxide and caspase 3 activation in HL-60 cells. Life Sci 68:2799-2811
24. Izzotti A, Cartiglia C, Lewtas J, De Flora S (2001) Increased DNA alterations in atherosclerotic lesions of individuals lacking the GSTM1 genotype. FASEB J 15:752-757
25. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J, Rosen R (1996) Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93:7-9
26. Kluijtmans LA, Kastelein JJ, Kastelein J, Lindemans J, Boers GH, Heil SG, Bruschke AV, Jukema JW, Van Den Heuvel LP, Trijbels FJ, Boerma GJ, Verheugt FW, Willems F, Blom HJ (1997) Thermolabile methylenetetrahydrofolate reductase in coronary artery disease. Circulation 96:2573-2577
27. Kruman II, Culmsee C, Chan SL, Kruman Y, Guo Z, Penix L Mattson MP (2000) Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci 20:6920-6926
28. Lee SH, Blair IA (2001) Oxidative DNA damage and cardiovascular disease. Trends Cardiovasc Med 11:148-155
29. Loscalzo J (1996) The oxidant stress of hyperhomocysteinemia. J Clin Invest 98:5-7
30. Ma J, Stampfer MJ, Giovanucci E, Artigas C, Hunter DJ, Fuchs C, Willett WC, Selhub J, Hennekens CH, Rozen R (1997) Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 57:1098-1102
31. Mager A, Lalezari S, Shohat T, Birnbaum Y, Adler Y, Magal N, Shohat M (1999) Methylenetetrahydrofolate reductase genotypes and early-onset coronary artery disease. Circulation 100:2406-2410
32. Miller JW (2000) Homocysteine, Alzheimer's disease, and cognitive function. Nutrition 16:675-677
33. Martinet W, Knaapen MW, De Meyer GR, Herman AG, Kockx MM (2002) Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation 106:927-932
34. Morita H, Taguchi J, Kurihara H, Kitaoka M, Kaneda H, Kurihara Y, Maemura K, Shindo T, Minamino T, Ohno M, Yamaoki K, Ogasawara K, Aizawa T, Suzuki S, Yazaki Y (1997) Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation 95:2032-2036
35. Piyathilake CJ, Macaluso M, Johanning GL, Whiteside M, Heimburger DC, Giulianoi A (2000) Methylenetetrahydrofolate reductase (MTHFR) polymorphism increases the risk of cervical intraepithelial neoplasia. Anticancer Res 20:1751-1757
36. Povey S, Lovering R, Bruford E, Wright M, Lush M, Wain H (2001) The HUGO Gene Nomenclature Committee (HGNC). Hum Genet 109:678-680
37. Ross JS, Stagliano NE, Donovan MJ, Breitbart RE, Ginsburg GS (2001) Atherosclerosis and cancer: Common molecular pathways of disease development and progression. Ann N Y Acad Sci 947:271-292
38. Ross R (1999) Atherosclerosis - An inflammatory disease. N Engl J Med 340:115-126
39. Singal R, Ginder GD (1999) DNA methylation. Blood 93:4059-4070
40. Skibola CF, Smith MT, Kane E, Roman E, Rollinson S, Cartwright RA, Morgan G (1999) Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci USA 96:12810-12815
41. Snedecor G, Cocharn W (1980) One-way classifications; Analysis of variance. In: Snedecor G, Cochran W (eds) Statistical Methods, 7th edn. Iowa State University Press, Des Moines, pp 215-237
42. Song C, Xing D, Tan W, Wei Q, Lin D (2001) Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res 61:3272-3275
43. Starkebaum G, Harlan JM (1986) Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest 77:1370-1376
44. Stern LL, Mason JB, Selhub J, Choi SW (2000) Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. Cancer Epidemiol Biomarkers Prev 9:849-853
45. Thambyrajah J, Townend JN (2000) Homocysteine and atherothrombosis-mechanisms for injury. Eur Heart J 21:967-974
46. Ulvik A, Evensen ET, Lien EA, Hoff G, Vollset SE, Majak BM, Ueland PM (2001) Smoking, folate and methylenetetrahydrofolate reductase status as interactive determinants of adenomatous and hyperplastic polyps of colorectum. Am J Med Genet 101:246-254
47. Van Schooten FJ, Hirvonen A, Maas LM, De Mol BA, Kleinjans JC, Bell DA, Durrer JD (1998) Putative susceptibility markers of coronary artery disease: Association between VDR genotype, smoking, and aromatic DNA adduct levels in human right atrial tissue. FASEB J 12:1409-1417
48. Wenstrom KD, Johanning GL, Owen J, Johnston KE, Acton S, Tamura T (2000) Role of amniotic fluid homocysteine level and of fetal 5,10-methylenetetrahydrafolate reductase genotype in the etiology of neural tube defects. Am J Med Genet 90:12-16